These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 25007962)
1. Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies. Holm M; Tjønneland A; Balslev E; Kroman N Breast Cancer Res Treat; 2014 Aug; 146(3):461-75. PubMed ID: 25007962 [TBL] [Abstract][Full Text] [Related]
2. A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. Nichol AM; Yerushalmi R; Tyldesley S; Lesperance M; Bajdik CD; Speers C; Gelmon KA; Olivotto IA J Clin Oncol; 2011 Dec; 29(36):4763-8. PubMed ID: 22105824 [TBL] [Abstract][Full Text] [Related]
3. Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand. Roder D; de Silva P; Zorbas H; Kollias J; Malycha P; Pyke C; Campbell I; Webster F Asian Pac J Cancer Prev; 2012; 13(4):1413-8. PubMed ID: 22799341 [TBL] [Abstract][Full Text] [Related]
5. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers. Karakas Y; Kertmen N; Lacin S; Aslan A; Demir M; Ates O; Aksoy S; Altundag K J BUON; 2017; 22(3):623-627. PubMed ID: 28730766 [TBL] [Abstract][Full Text] [Related]
6. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer. Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461 [TBL] [Abstract][Full Text] [Related]
7. Bilateral breast cancer, synchronous and metachronous; differences and outcome. Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697 [TBL] [Abstract][Full Text] [Related]
8. The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018). Pan B; Xu Y; Zhou YD; Yao R; Wu HW; Zhu QL; Wang CJ; Mao F; Lin Y; Shen SJ; Sun Q Cancer Med; 2019 Jun; 8(6):2908-2918. PubMed ID: 31038845 [TBL] [Abstract][Full Text] [Related]
9. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up. Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer mortality in synchronous bilateral breast cancer patients. Mejdahl MK; Wohlfahrt J; Holm M; Balslev E; Knoop AS; Tjønneland A; Melbye M; Kroman N Br J Cancer; 2019 Apr; 120(7):761-767. PubMed ID: 30804429 [TBL] [Abstract][Full Text] [Related]
11. Prognosis of synchronous bilateral breast cancer. Irvine T; Allen DS; Gillett C; Hamed H; Fentiman IS Br J Surg; 2009 Apr; 96(4):376-80. PubMed ID: 19283743 [TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Disparities in Synchronous and Metachronous Bilateral Breast Cancer. Hewitt DB; Li Y; Bhattacharyya O; Fisher JL; Stover D; Obeng-Gyasi S J Racial Ethn Health Disparities; 2023 Jun; 10(3):1035-1046. PubMed ID: 35386052 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Pathologic Features of Clinically Occult Synchronous Bilateral Breast Cancers. Santiago L; Whitman G; Wang C; Dogan BE Curr Probl Diagn Radiol; 2018 Sep; 47(5):305-310. PubMed ID: 28935459 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics of synchronous bilateral breast carcinomas. Report of 30 patients. Ben Hassouna J; Damak T; Chargui R; Slimene M; Chkir A; Ayadi MA; Mtallah M; Hechiche M; Gamoudi A; Khomsi F; Ben Dhiab T; Rahal K Tunis Med; 2008 Feb; 86(2):155-9. PubMed ID: 18444533 [TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
17. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056 [TBL] [Abstract][Full Text] [Related]
18. National trends of synchronous bilateral breast cancer incidence in the United States. Sakai T; Ozkurt E; DeSantis S; Wong SM; Rosenbaum L; Zheng H; Golshan M Breast Cancer Res Treat; 2019 Nov; 178(1):161-167. PubMed ID: 31325072 [TBL] [Abstract][Full Text] [Related]
19. Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer. Huang L; Liu Q; Lang GT; Cao AY; Shao ZM Front Oncol; 2020; 10():27. PubMed ID: 32117708 [No Abstract] [Full Text] [Related]
20. [A retrospective evaluation of clinicalopathologic characteristics and prognostic factors for synchronous bilateral breast cancer in a single center]. Xin L; Xiang HY; Liu YH Zhonghua Yi Xue Za Zhi; 2021 Feb; 101(6):410-415. PubMed ID: 33611890 [No Abstract] [Full Text] [Related] [Next] [New Search]